Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009

BACKGROUND: New emerging infections have no known treatment. Assessing potential drugs for safety and efficacy enables clinicians to make evidence-based treatment decisions and contributes to overall outbreak control. However, it is difficult to launch clinical trials in the unpredictable environmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Rojek, Amanda M., Martin, Genevieve E., Horby, Peter W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441224/
https://www.ncbi.nlm.nih.gov/pubmed/32825816
http://dx.doi.org/10.1186/s12916-020-01732-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441224/
https://www.ncbi.nlm.nih.gov/pubmed/32825816
http://dx.doi.org/10.1186/s12916-020-01732-5

Ejemplares similares